Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Messenger RNA vaccines against SARS-CoV-2.

Literature DB >> 33740443

Messenger RNA vaccines against SARS-CoV-2.

Abstract

The first two vaccines proven to be effective for inhibiting COVID-19 illness were both mRNA, achieving 95% efficacy (and safety) among 74,000 participants (half receiving placebo) after intramuscular delivery of two shots, 3-4 weeks apart. To view this Bench to Bedside, open or download the PDF.

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2021 PMID： 33740443 PMCID： PMC7805392 DOI： 10.1016/j.cell.2020.12.039

Source DB: PubMed Journal: Cell ISSN： 0092-8674 Impact factor: 41.582

2 in total

1. An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.

Authors: Lisa A Jackson; Evan J Anderson; Nadine G Rouphael; Paul C Roberts; Mamodikoe Makhene; Rhea N Coler; Michele P McCullough; James D Chappell; Mark R Denison; Laura J Stevens; Andrea J Pruijssers; Adrian McDermott; Britta Flach; Nicole A Doria-Rose; Kizzmekia S Corbett; Kaitlyn M Morabito; Sijy O'Dell; Stephen D Schmidt; Phillip A Swanson; Marcelino Padilla; John R Mascola; Kathleen M Neuzil; Hamilton Bennett; Wellington Sun; Etza Peters; Mat Makowski; Jim Albert; Kaitlyn Cross; Wendy Buchanan; Rhonda Pikaart-Tautges; Julie E Ledgerwood; Barney S Graham; John H Beigel
Journal: N Engl J Med Date: 2020-07-14 Impact factor: 91.245

2. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

Authors: Fernando P Polack; Stephen J Thomas; Nicholas Kitchin; Judith Absalon; Alejandra Gurtman; Stephen Lockhart; John L Perez; Gonzalo Pérez Marc; Edson D Moreira; Cristiano Zerbini; Ruth Bailey; Kena A Swanson; Satrajit Roychoudhury; Kenneth Koury; Ping Li; Warren V Kalina; David Cooper; Robert W Frenck; Laura L Hammitt; Özlem Türeci; Haylene Nell; Axel Schaefer; Serhat Ünal; Dina B Tresnan; Susan Mather; Philip R Dormitzer; Uğur Şahin; Kathrin U Jansen; William C Gruber
Journal: N Engl J Med Date: 2020-12-10 Impact factor: 91.245

2 in total

11 in total

1. Hijacking of Cellular Functions by Severe Acute Respiratory Syndrome Coronavirus-2. Permeabilization and Polarization of the Host Lipid Membrane by Viroporins.

Authors: Emmanuelle Bignon; Marco Marazzi; Antonio Monari
Journal: J Phys Chem Lett Date: 2022-05-20 Impact factor: 6.888

2. Unleashing the potential of cell membrane-based nanoparticles for COVID-19 treatment and vaccination.

Authors: Miguel Pereira-Silva; Gaurav Chauhan; Matthew D Shin; Clare Hoskins; Marc J Madou; Sergio O Martinez-Chapa; Nicole F Steinmetz; Francisco Veiga; Ana Cláudia Paiva-Santos
Journal: Expert Opin Drug Deliv Date: 2021-06-06 Impact factor: 6.648

3. Comparison of five commercial anti-SARS-CoV-2 total antibodies and IgG immunoassays after vaccination with BNT162b2 mRNA.

Authors: Elisa Danese; Martina Montagnana; Gian Luca Salvagno; Matteo Gelati; Denise Peserico; Laura Pighi; Simone de Nitto; Brandon M Henry; Stefano Porru; Giuseppe Lippi
Journal: J Med Biochem Date: 2021-09-03 Impact factor: 3.402

4. Potential Positive Effects of COVID-19 on Cancer Care: A Window of Opportunity.

Authors: Emmanouil Damilakis
Journal: Int J Public Health Date: 2022-02-25 Impact factor: 3.380

5. T cell response to intact SARS-CoV-2 includes coronavirus cross-reactive and variant-specific components.

Authors: Lichen Jing; Xia Wu; Maxwell P Krist; Tien-Ying Hsiang; Victoria L Campbell; Christopher L McClurkan; Sydney M Favors; Lawrence A Hemingway; Charmie Godornes; Denise Q Tong; Stacy Selke; Angela C LeClair; Chu-Woo Pyo; Daniel E Geraghty; Kerry J Laing; Anna Wald; Michael Gale; David M Koelle
Journal: JCI Insight Date: 2022-03-22

6. A retrospective analysis of social media posts pertaining to COVID-19 vaccination side effects.

Authors: Max-Philipp Lentzen; Viola Huebenthal; Rolf Kaiser; Matthias Kreppel; Joachim E Zoeller; Matthias Zirk
Journal: Vaccine Date: 2021-11-22 Impact factor: 3.641

7. mRNA-Loaded Lipid Nanoparticles Targeting Dendritic Cells for Cancer Immunotherapy.

Authors: Kosuke Sasaki; Yusuke Sato; Kento Okuda; Kazuki Iwakawa; Hideyoshi Harashima
Journal: Pharmaceutics Date: 2022-07-28 Impact factor: 6.525

8. Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination.

Authors: Gian Luca Salvagno; Brandon M Henry; Giovanni di Piazza; Laura Pighi; Simone De Nitto; Damiano Bragantini; Gian Luca Gianfilippi; Giuseppe Lippi
Journal: Diagnostics (Basel) Date: 2021-05-04

9. Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How?

Authors: Giuseppe Lippi; Brandon Michael Henry; Mario Plebani
Journal: Diagnostics (Basel) Date: 2021-05-25

Review 10. Adjuvants: friends in vaccine formulations against infectious diseases.

Authors: G G Guerrero Manriquez; I Tuero
Journal: Hum Vaccin Immunother Date: 2021-07-21 Impact factor: 4.526